đź“‹ FDA Reference

flowtriever retrieval aspiration system

Inari Medical

Summary: The FlowTriever Retrieval Aspiration System is a medical device used for mechanical thrombectomy in patients with pulmonary embolism. It is primarily used by interventional radiologists and cardiologists to remove clots from the pulmonary arteries.

FDA Clearance Information

Pathway 510K
Decision Date December 4, 2020
Product Code QEW
Device Class Class 2
Evidence 14 studies

The FlowTriever Retrieval Aspiration System, manufactured by Inari Medical, was cleared through the FDA 510k pathway on December 4, 2020. It is a Class 2 medical device.

What It Is

The FlowTriever Retrieval Aspiration System is a mechanical thrombectomy device designed to remove thrombi from the pulmonary arteries. It works by using large-bore catheters to aspirate and retrieve clots, providing a minimally invasive option for treating pulmonary embolism. The system is designed to reduce clot burden without the need for thrombolytic drugs, which can be beneficial in patients at risk for bleeding.

Clinical Applications

This device is commonly used in the treatment of intermediate- to high-risk pulmonary embolism, particularly in patients who may not be candidates for thrombolytic therapy. It is typically employed in hospital settings, such as interventional radiology or cardiology suites. The primary users are interventional radiologists, cardiologists, and vascular surgeons who specialize in endovascular procedures.

Indications for Use

The FDA-cleared indications for the FlowTriever Retrieval Aspiration System include the treatment of pulmonary embolism, specifically for patients with significant clot burden in the pulmonary arteries. It is intended for use in patients who are at intermediate to high risk and may benefit from mechanical clot removal.

Practical Considerations

The FlowTriever system is available in various catheter sizes to accommodate different patient anatomies and clot burdens. It is compatible with standard guidewires and introducer sheaths. Operators should be familiar with large-bore catheter techniques and have experience in managing potential complications such as vascular access site bleeding.

Related Literature

The linked study discusses a novel case of cardiac tamponade following the use of the FlowTriever system for percutaneous pulmonary embolectomy. The study highlights the potential risks associated with large-bore catheter use in the pulmonary vasculature. While the FlowTriever system is effective in reducing clot burden, clinicians should be aware of and prepared to manage possible complications. The study is limited by its focus on a single case, emphasizing the need for further research to better understand the risk profile of the device.

Linked Studies (14)

PubMed • 2026

Percutaneous Aspiration of a Large Mitral Valve Vegetation With Full-Body Protection: A Novel Approach.

JACC. Case reports

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Novel percutaneous aspiration thrombectomy in Fontan conduit obstruction with cardiogenic shock. Case report.

International journal of cardiology. Congenital heart disease

Case Report View Source →
PubMed • 2025

Early Experience Using Venous Sheath With Embolic Protection During Thrombectomy of Inferior Vena Cava and Complex Iliofemoral Deep Vein Thrombosis.

The American surgeon

Case Series View Source →
PubMed • 2024

Percutaneous pulmonary aspiration thrombectomy in an adolescent fontan patient using a large-bore system.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Other View Source →
PubMed • 2024

Pulmonary Embolism With Syncope Treated With Inari FlowTriever®.

Cureus

View Source →
PubMed • 2024

[Interventional therapy of pulmonary embolism - update].

Deutsche medizinische Wochenschrift (1946)

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Procedure-Related Mortality in Aspiration Thrombectomy for Pulmonary Embolism: A MAUDE Database Analysis of the Inari FlowTriever and Penumbra Indigo Systems.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study.

Circulation. Cardiovascular interventions

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Mechanical thrombectomy of inferior vena cava filter-associated caval thrombosis using FlowTriever and ClotTriever systems.

Journal of vascular surgery. Venous and lymphatic disorders

Other View Source →
PubMed • 2022

Percutaneous FlowTriever Retrieval/Aspiration System for Impending Paradoxical Embolism: A New Tool?

JACC. Cardiovascular interventions

View Source →
PubMed • 2022

A Novel Case of Cardiac Tamponade after Percutaneous Pulmonary Embolectomy Using the FlowTriever Retrieval/Aspiration System.

European journal of case reports in internal medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study.

JACC. Cardiovascular interventions

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2018

Percutaneous Pulmonary Embolectomy Using the FlowTriever Retrieval/Aspiration System.

Journal of vascular and interventional radiology : JVIR

View Source →
ClinicalTrials.gov

FlowTriever2 Pulmonary Embolectomy Clinical Study

View Source →

Frequently Asked Questions

What is the FlowTriever Retrieval Aspiration System used for?

It is used for mechanical thrombectomy in patients with pulmonary embolism to remove clots from the pulmonary arteries.

What specialties typically use this device?

Interventional radiologists, cardiologists, and vascular surgeons typically use this device in hospital settings.

What are the FDA-cleared indications?

The device is indicated for the treatment of pulmonary embolism in patients with significant clot burden, particularly those at intermediate to high risk.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.